MedPath

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.

Phase 3
Terminated
Conditions
NSCLC
Registration Number
NCT00269828
Lead Sponsor
CTI BioPharma
Brief Summary

This is a randomized, open-label, multinational, phase III study in women with histologically- or cytologically-confirmed advanced NSCLC who are chemotherapy naรฏve and have PS 2. Study drug will be administered on day 1 of each 21 day cycle

Detailed Description

See Summary

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
600
Inclusion Criteria
  1. Female.

  2. Histologically- or cytologically-confirmed diagnosis of NSCLC.

  3. ECOG performance score of 2.

  4. Patients who meet one of the following criteria:

    • Stage IIIB who are not candidates for combined modality therapy (primary radiation therapy or surgery), or
    • Stage IV.
  5. Age greater than or equal to 18 years.

  6. Adequate bone marrow function

  7. Adequate renal function

  8. Adequate hepatic function

  9. Patients with known brain metastases must have received standard antitumor treatment for their CNS metastases as defined by the site's institutional standards.

  10. Patients who have had major surgery must be fully recovered from the surgery.

  11. Ability to comply with the visit schedule and assessments required by the protocol.

  12. For patients of reproductive potential, commitment to use adequate contraception.

  13. Signed approved informed consent, with understanding of study procedures.

  14. Agreement to begin study therapy within 8 calendar days after randomization.

Exclusion Criteria
  1. Any intolerance to poly-L-glutamic acid, Poloxamer 188, dibasic sodium phosphate, monobasic sodium phosphate (the excipients of CT-2103).
  2. Evidence of small cell carcinoma, carcinoid, or mixed small cell/non-small cell histology.
  3. Any prior systemic chemotherapy for the treatment of lung cancer. This includes systemic radiosensitizers used to treat brain metastases and any biologic agent.
  4. Concurrent primary malignancies except for carcinoma in situ or non-melanoma skin cancer.
  5. Grade 2 or greater neuropathy.
  6. Evidence of significant unstable neurological symptoms within the 4 weeks before study randomization. (If unstable neurologic symptoms resulted from brain metastases, patient must meet inclusion criteria number 9).
  7. Clinically significant active infection for which active therapy is underway.
  8. Investigational therapy within 4 weeks before randomization, unless local requirements are more stringent.
  9. Unstable medical conditions including unstable angina or myocardial infarction within the past 6 months before randomization. Patients with evidence of cardiac conduction abnormalities are eligible if their cardiac status is stable.
  10. Pregnant women or nursing mothers.
  11. Any circumstance at the time of study entry that would preclude completion of the study or the required follow-up.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The primary objective of this study is to compare the overall survival of female patients randomized to CT-2103 to that of female patients randomized to paclitaxel.
Secondary Outcome Measures
NameTimeMethod
Secondary objectives are to compare the progression-free survival, response rate, disease control, clinical benefit, quality of life, and the safety and tolerability of the treatment arms.

Trial Locations

Locations (142)

Hospital General de Agudos "Dr Teodoro Alvarez"

๐Ÿ‡ฆ๐Ÿ‡ท

Buenos Aires, Argentina

LUCEN

๐Ÿ‡ฆ๐Ÿ‡ท

Cuidad Autonoma de Buenos Aires, Argentina

ISIS Clinica Especializada

๐Ÿ‡ฆ๐Ÿ‡ท

Urquiza, Argentina

Regional Oncology Dispensary with Inpatient sector

๐Ÿ‡ง๐Ÿ‡ฌ

Veliko Tarnovo, Bulgaria

Jewish General Hospital

๐Ÿ‡จ๐Ÿ‡ฆ

Montreal, Quebec, Canada

University of Debrecen, Pulmonology Clinic

๐Ÿ‡ญ๐Ÿ‡บ

Debreen, Hungary

Arizona Hematology Oncology

๐Ÿ‡บ๐Ÿ‡ธ

Tucson, Arizona, United States

District Oncology Dispensary

๐Ÿ‡ง๐Ÿ‡ฌ

Plovdiv, Bulgaria

Columbia Basin HEM/ONC

๐Ÿ‡บ๐Ÿ‡ธ

Kennewick, Washington, United States

CETEN

๐Ÿ‡ฆ๐Ÿ‡ท

Beunos Aires, Argentina

Regional Oncology Dispensary with Inpatient Secot-Sofia District

๐Ÿ‡ง๐Ÿ‡ฌ

Sogia, Bulgaria

Oncology Pharmacy

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

Sanatorio Parque

๐Ÿ‡ฆ๐Ÿ‡ท

Rosario, Santa Fe, Argentina

Instituto Alexander Fleming

๐Ÿ‡ฆ๐Ÿ‡ท

Ciudad de Buenos Aires, Argentina

JPS Center for Cancer Care

๐Ÿ‡บ๐Ÿ‡ธ

Fort Worth, Texas, United States

Erzsebet Hospital

๐Ÿ‡ญ๐Ÿ‡บ

Sopron, Hungary

Wythenshaw Hospital, Pharmacy Department

๐Ÿ‡ฌ๐Ÿ‡ง

Manchester, United Kingdom

CIMA Chihuahua

๐Ÿ‡ฒ๐Ÿ‡ฝ

Chihuahua, Chih, Mexico

Hospital General

๐Ÿ‡ฒ๐Ÿ‡ฝ

Durango, Dgo., Mexico

Instituto Estatal de Cancerologia "Dr. Arturo Beltran Ortega"

๐Ÿ‡ฒ๐Ÿ‡ฝ

Acapulco, Gro, Mexico

Chelyabinsk Regional Oncology Center

๐Ÿ‡ท๐Ÿ‡บ

Chelyabinsk, Russian Federation

Krasnodar City Oncology Center

๐Ÿ‡ท๐Ÿ‡บ

Krasnodar, Russian Federation

The Royal Bournemouth Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Bournemouth, United Kingdom

Southhampton General Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Southhampton, United Kingdom

Zaporizhzhya Regional Oncology Dispensary

๐Ÿ‡บ๐Ÿ‡ฆ

Zaprizhzhya, Ukraine

Comprehensive Blood and Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Bakersfield, California, United States

West Kentucky Hematology & Oncology Group, PSC

๐Ÿ‡บ๐Ÿ‡ธ

Paducah, Kentucky, United States

New York Medical Collegw

๐Ÿ‡บ๐Ÿ‡ธ

Valhalla, New York, United States

University of Cleveland

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland, Ohio, United States

The Cleveland Clinic Foundation, Taussig Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland, Ohio, United States

Mary Crowley Medical Research Center

๐Ÿ‡บ๐Ÿ‡ธ

Dallas, Texas, United States

Pacific Cancer Medical Center, Inc

๐Ÿ‡บ๐Ÿ‡ธ

Anaheim, California, United States

Tower Cancer Research Foundation

๐Ÿ‡บ๐Ÿ‡ธ

Beverly Hills, California, United States

Providence St. Joseph Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Burbank, California, United States

Hematology/Oncology Group of Fresno, Inc

๐Ÿ‡บ๐Ÿ‡ธ

Fresno, California, United States

Comprehensive Cancer Center-Research Office

๐Ÿ‡บ๐Ÿ‡ธ

Glendale, California, United States

Loma Linda University Cancer Institute

๐Ÿ‡บ๐Ÿ‡ธ

Loma Linda, California, United States

Pacific Shores Medical Group

๐Ÿ‡บ๐Ÿ‡ธ

Long Beach, California, United States

Medical Oncology Care Associates

๐Ÿ‡บ๐Ÿ‡ธ

Orange, California, United States

The Cancer Research and Prevention Center

๐Ÿ‡บ๐Ÿ‡ธ

Soquel, California, United States

Bethesda Research Center

๐Ÿ‡บ๐Ÿ‡ธ

Boynton Beach, Florida, United States

Florida Wellcare

๐Ÿ‡บ๐Ÿ‡ธ

Inverness, Florida, United States

Broward Oncology Associates

๐Ÿ‡บ๐Ÿ‡ธ

Fort Lauderdale, Florida, United States

Oncology-Hematology Associates of West Broward

๐Ÿ‡บ๐Ÿ‡ธ

Tamarac, Florida, United States

Cancer & Blood Disease Center

๐Ÿ‡บ๐Ÿ‡ธ

Lecanto, Florida, United States

Joliet Oncology Hematology Associates, Ltd.

๐Ÿ‡บ๐Ÿ‡ธ

Joliet, Illinois, United States

Loyola University Health Systems

๐Ÿ‡บ๐Ÿ‡ธ

Maywood, Illinois, United States

Mid-Illinois HEM & ONC Assoc.

๐Ÿ‡บ๐Ÿ‡ธ

Normal, Illinois, United States

Northern Indiana Cancer Research Consortium

๐Ÿ‡บ๐Ÿ‡ธ

South Bend, Indiana, United States

Associated Physicians & Surgeons Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Terre Haute, Indiana, United States

Kentucky Cancer Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Hazard, Kentucky, United States

West Michigan Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Kalamazoo, Michigan, United States

Oncology Care Associates, PLLC

๐Ÿ‡บ๐Ÿ‡ธ

Saint Joseph, Michigan, United States

St. Louis Cancer Care Center

๐Ÿ‡บ๐Ÿ‡ธ

Chesterfield, Missouri, United States

Columbia Comprehensive Cancer Care Clinics

๐Ÿ‡บ๐Ÿ‡ธ

Columbia, Missouri, United States

Bond Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Rolla, Missouri, United States

Washington University Siteman Cancer Center Pharmacy

๐Ÿ‡บ๐Ÿ‡ธ

Saint Louis, Missouri, United States

Our Lady of Mercy Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Bronx, New York, United States

Suny Downstate Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Brooklyn, New York, United States

Interlakes Foundation, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Rochester, New York, United States

UNC Chapel Hill Oncology Protocol Office

๐Ÿ‡บ๐Ÿ‡ธ

Chapel Hill, North Carolina, United States

Alamance Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Burlington, North Carolina, United States

Leo Jenkins Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Greenville, North Carolina, United States

Northwestern Carolina Oncology & Hematology

๐Ÿ‡บ๐Ÿ‡ธ

Hickory, North Carolina, United States

St. Alexius Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Bismarck, North Dakota, United States

Metro Health Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland, Ohio, United States

Signal Point Hematology/Oncology, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

Middletown, Ohio, United States

Centenario Hospital Miguel Hidalgo

๐Ÿ‡ฒ๐Ÿ‡ฝ

Aguascalientes, Ags., Mexico

Hospital Star Medica Morelina

๐Ÿ‡ฒ๐Ÿ‡ฝ

Morelia, Michoacan, Mexico

Hospital General Regional

๐Ÿ‡ฒ๐Ÿ‡ฝ

Veracruz, Mexico

Kujawsko-Pomorskie Centrum Pulmunologii

๐Ÿ‡ต๐Ÿ‡ฑ

Bydgoszcz, Poland

SPSK nr l im. Przemienienia AM w Poznaniu

๐Ÿ‡ต๐Ÿ‡ฑ

Poznan, Poland

Dolnoslaskie Centrum Chorob Pluc ul. Grabiszynska 105

๐Ÿ‡ต๐Ÿ‡ฑ

Wroclaw, Poland

Prof. Dr. Al. Trestioreanu Institute of Oncology

๐Ÿ‡ท๐Ÿ‡ด

Bucharest, Romania

Emergency Clinical County Hospital

๐Ÿ‡ท๐Ÿ‡ด

Craiova, Romania

Oradea Clinical County Hospital

๐Ÿ‡ท๐Ÿ‡ด

Oradea, Romania

SI Russian Oncological Scientific Center after N.N. Blokhim RAMS

๐Ÿ‡ท๐Ÿ‡บ

Moscow, Russian Federation

Volyn Regional Oncology Dispensary

๐Ÿ‡บ๐Ÿ‡ฆ

Lutsk, Ukraine

Hospital for Thoracic Diseases of Csongrad Country

๐Ÿ‡ญ๐Ÿ‡บ

Deszk, Hungary

Pulmonology Institute of Veszprem County

๐Ÿ‡ญ๐Ÿ‡บ

Farkasgyepu, Hungary

Barany County Hospital

๐Ÿ‡ญ๐Ÿ‡บ

Pecs, Hungary

Hospital Central "Dr. Ignacio Morones Prieto"

๐Ÿ‡ฒ๐Ÿ‡ฝ

San Luis Potosi, Mexico

MSc Grezegorz Jedrejezak

๐Ÿ‡ต๐Ÿ‡ฑ

Wroclaw, Poland

"Prof. Dr. I. Chiricuta" Institute of Oncology

๐Ÿ‡ท๐Ÿ‡ด

Cluj-Napoca, Romania

Moscow Municpal Oncology Hospital #62

๐Ÿ‡ท๐Ÿ‡บ

Moscow Region, Russian Federation

Omsk Regional Oncology Center

๐Ÿ‡ท๐Ÿ‡บ

Omsk, Russian Federation

Orenburg Regional Oncology Clinical Center

๐Ÿ‡ท๐Ÿ‡บ

Orenburg, Russian Federation

Donetsk Regional Antineoplastic Center

๐Ÿ‡บ๐Ÿ‡ฆ

Donetsk, Ukraine

University Mulitprofile Hospital for Active Treatment "Sveta Marina"

๐Ÿ‡ง๐Ÿ‡ฌ

Varna, Bulgaria

Heritage Physician Group, Oncology

๐Ÿ‡บ๐Ÿ‡ธ

Hot Springs, Arkansas, United States

Essex Oncology of North Jersey, PA

๐Ÿ‡บ๐Ÿ‡ธ

Belleville, New Jersey, United States

Hospital of the Chest Desease of the Hungarian Reformed Church

๐Ÿ‡ญ๐Ÿ‡บ

Mosdos, Hungary

Karolina Hospital

๐Ÿ‡ญ๐Ÿ‡บ

Mosonmagyarovar, Hungary

Krakowski Szpital Specjelistyczny

๐Ÿ‡ต๐Ÿ‡ฑ

Kawkow, Poland

Institutul Oncologie - Clinic de Oncologie Medicala

๐Ÿ‡ท๐Ÿ‡ด

Bucharest, Romania

Timisoara Emergency Clinical Municipal Hospital

๐Ÿ‡ท๐Ÿ‡ด

Timisoara, Romania

St. Petersbrug State Medical Pavlov University

๐Ÿ‡ท๐Ÿ‡บ

St. Petersburg, Russian Federation

Uzhgorod National University, Regional Clinical Oncology Dispensary

๐Ÿ‡บ๐Ÿ‡ฆ

Uzhgorod, Ukraine

Regional Oncology Dispensary with Inpatient Sector

๐Ÿ‡ง๐Ÿ‡ฌ

Varna, Bulgaria

Montana Cancer Specialists

๐Ÿ‡บ๐Ÿ‡ธ

Missoula, Montana, United States

Genesis Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Hot Springs, Arkansas, United States

Erzsebet Juhasz

๐Ÿ‡ญ๐Ÿ‡บ

Budapest, Hungary

Centeral ClinicalHospital of the President o the Russian Federation

๐Ÿ‡ท๐Ÿ‡บ

Moscow, Russian Federation

Atlanta HEM ONC

๐Ÿ‡บ๐Ÿ‡ธ

Manasquan, New Jersey, United States

Cabrini Center for Cancer Care

๐Ÿ‡บ๐Ÿ‡ธ

Alexandria, Louisiana, United States

Instituto Oncologico de Cordoba - IONC

๐Ÿ‡ฆ๐Ÿ‡ท

Cordoba, Argentina

Hospital for Pulmonological Diseases of the Bekes County

๐Ÿ‡ญ๐Ÿ‡บ

Gyula, Hungary

Sanatorium for Pulmonological Diseases

๐Ÿ‡ญ๐Ÿ‡บ

Torokbalint, Hungary

Desert Oasis Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Casa Grande, Arizona, United States

Oncology and Hematology Specialist, PA

๐Ÿ‡บ๐Ÿ‡ธ

Mountain Lakes, New Jersey, United States

Hospital Privado de Comunidad

๐Ÿ‡ฆ๐Ÿ‡ท

Buenos Aires, Argentina

District Oncolodispensary with Impatient sector

๐Ÿ‡ง๐Ÿ‡ฌ

Rousse, Bulgaria

Military Medical Academy

๐Ÿ‡ง๐Ÿ‡ฌ

Sofia, Bulgaria

Centro Estatal de Cancerologia

๐Ÿ‡ฒ๐Ÿ‡ฝ

Chihuahua, Mexico

Charleston Hematology Oncology

๐Ÿ‡บ๐Ÿ‡ธ

Charleston, South Carolina, United States

Centro Anticanceroso de la Cruz Roja Mexicana de Merida

๐Ÿ‡ฒ๐Ÿ‡ฝ

Merida, Yucatan, Mexico

Instiute of Oncology under AMS of Ukraine

๐Ÿ‡บ๐Ÿ‡ฆ

Kiev, Ukraine

Centrum Onkologii Ziemii Lubelskiej

๐Ÿ‡ต๐Ÿ‡ฑ

Lublin, Poland

University Multiprofile Hospital for Active Treatment "Sveta Marina"

๐Ÿ‡ง๐Ÿ‡ฌ

Varna, Bulgaria

Monterrey International Research Center

๐Ÿ‡ฒ๐Ÿ‡ฝ

Monterrey, N.l., Mexico

Centro Estatal de Canceologia

๐Ÿ‡ฒ๐Ÿ‡ฝ

Jalapa, Veracruz, Mexico

St. Petersburg City Clinical Oncology Center

๐Ÿ‡ท๐Ÿ‡บ

Saint Petersburg, Russian Federation

Ivano-Frankovsk Regional Oncology Center, Ivano-Frankovsk Medical University

๐Ÿ‡บ๐Ÿ‡ฆ

Ivano-Frankovsk, Ukraine

Vinnitsa State Medical University

๐Ÿ‡บ๐Ÿ‡ฆ

Vynnytsya, Ukraine

Moscow Oncology Clinical Dispensary #1

๐Ÿ‡ท๐Ÿ‡บ

Moscow, Russian Federation

SI Russian Oncological Scientific Center after N.N. Blokhin RAMS

๐Ÿ‡ท๐Ÿ‡บ

Moscow, Russian Federation

Zaklad Opieki Zdrowotnej Ministerstaw Spraw Wewnetrznych i Administraeji

๐Ÿ‡ต๐Ÿ‡ฑ

Olsztyn, Poland

Mazowleckie Centrum leczenia Chorob Pluc i Gruzlicy

๐Ÿ‡ต๐Ÿ‡ฑ

Otwock, Poland

Clinical County Hospital

๐Ÿ‡ท๐Ÿ‡ด

Sibiu, Romania

Wielkopolskie Centrum Chorob Pluc i Gruzlicy, Samodzielmy Publiczny ZOZ

๐Ÿ‡ต๐Ÿ‡ฑ

Poznan, Poland

Lenigrad Regional Oncology Center

๐Ÿ‡ท๐Ÿ‡บ

St. Petersburg, Russian Federation

Leningrad Regional Clinical Hospital

๐Ÿ‡ท๐Ÿ‡บ

St. Petersburg, Russian Federation

Saint Louis University

๐Ÿ‡บ๐Ÿ‡ธ

Saint Louis, Missouri, United States

Cancer Treatment Services

๐Ÿ‡บ๐Ÿ‡ธ

Corning, New York, United States

Guthrie Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Sayre, New York, United States

Hubert H. Humphrey Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Robbinsdale, Minnesota, United States

San Juan Oncology Association

๐Ÿ‡บ๐Ÿ‡ธ

Farmington, New Mexico, United States

Hematology Oncology Speaclist

๐Ÿ‡บ๐Ÿ‡ธ

Tampa, Florida, United States

Dayton Clinical Oncology Program

๐Ÿ‡บ๐Ÿ‡ธ

Dayton, Ohio, United States

The Family Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Collierville, Tennessee, United States

Sierra Nevada Oncology Care

๐Ÿ‡บ๐Ÿ‡ธ

Carson City, Nevada, United States

Hospital Dr. Angel Leano

๐Ÿ‡ฒ๐Ÿ‡ฝ

Zapopan, Jalisco, Mexico

ยฉ Copyright 2025. All Rights Reserved by MedPath